These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7686288)

  • 41. G-CSF treatment of leucopenia during fractionated radiotherapy.
    Hess CF; Schmidberger H; Bamberg M
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):923-4. PubMed ID: 7518817
    [No Abstract]   [Full Text] [Related]  

  • 42. Recombinant human G-CSF: how wide is the field of clinical applicability?
    Locatelli F; Pedrazzoli P
    Haematologica; 1995; 80(3):199-205. PubMed ID: 7545634
    [No Abstract]   [Full Text] [Related]  

  • 43. Positive response to granulocyte-colony-stimulating factor in dyskeratosis congenita before matched unrelated bone marrow transplantation.
    Pritchard SL; Junker AK
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):186-7. PubMed ID: 7513138
    [No Abstract]   [Full Text] [Related]  

  • 44. Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor.
    Marks LB; Friedman HS; Kurtzberg J; Oakes WJ; Hockenberger BM
    Med Pediatr Oncol; 1992; 20(3):240-2. PubMed ID: 1374149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different responses to granulocyte colony-stimulating factor treatment in siblings with alloimmune neonatal neutropenia.
    Latini G; Del Vecchio A; Rosati E; Borzini P; Chirico G; Rondini G
    Acta Paediatr; 1999 Dec; 88(12):1407-9. PubMed ID: 10626532
    [No Abstract]   [Full Text] [Related]  

  • 46. A randomised vehicle controlled multicenter dose finding phase. II. Study of glycosylated rhuG-CSF in 121 patients after bone marrow transplantation.
    Scarffe JH
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():365-7. PubMed ID: 1284308
    [No Abstract]   [Full Text] [Related]  

  • 47. The use of G-CSF during craniospinal irradiation.
    Marks LB; Halperin EC
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):905-6; discussion 907. PubMed ID: 7688363
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of G-CSF in a patient with Hunter syndrome receiving bone marrow transplantation.
    Miniero R; Busca A; Vassallo E; Madon E
    Am J Hematol; 1994 Sep; 47(1):59-60. PubMed ID: 7518996
    [No Abstract]   [Full Text] [Related]  

  • 49. Minimum effective dose and duration to reverse neutropenia in non-cancer patients with advanced HIV disease.
    Hermans P; Franchioly P; Thioux C; Gray SJ; Vannerom H; Clumeck N
    AIDS; 1996 Aug; 10(9):1050-1. PubMed ID: 8853746
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical appearance of a post-transplant lymphoma following G-CSF therapy.
    Johnson DW; Herzig KA
    Nephrol Dial Transplant; 1999 Jul; 14(7):1806-7. PubMed ID: 10435908
    [No Abstract]   [Full Text] [Related]  

  • 51. [Variations of Gm ET Inv phenotypes associated with allogenic bone marrow grafts].
    Rivat L; Ropartz C; Amiel JL; Schwarzenberg L; Mathé G
    Bull Inst Natl Sante Rech Med; 1968; 23(3):533-47. PubMed ID: 4880038
    [No Abstract]   [Full Text] [Related]  

  • 52. [Reduction by azathioprine of inhibition of allogenic bone marrow grafts by prior blood transfusions].
    Mathé G
    Rev Fr Etud Clin Biol; 1966 Dec; 11(10):1026-7. PubMed ID: 5342423
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation.
    Schwabe M; Hartert AM; Bertz H; Finke J
    Eur J Clin Invest; 2004 Nov; 34(11):759-65. PubMed ID: 15530149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
    Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
    Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Place of G-CSF in allogenic bone marrow grafts].
    Gluckman E
    Pathol Biol (Paris); 1993 Jan; 41(1):51. PubMed ID: 7686288
    [No Abstract]   [Full Text] [Related]  

  • 56. [Autologous transplantation of hematopoietic stem cells and growth factors].
    Harousseau JL
    Pathol Biol (Paris); 1993 Jan; 41(1):50. PubMed ID: 7686287
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.